Clinical Trials Arena August 7, 2024
Chest analysis software INSIGHT CXR demonstrated superior performance in TB detection compared to 11 other AI-based products.
Medical AI company Lunit’s chest X-ray analysis software INSIGHT CXR has demonstrated superior performance in tuberculosis (TB) detection, as highlighted by an independent study.
The study, published in The Lancet Digital Health, showed that INSIGHT CXR achieved the highest accuracy out of 12 tested AI-based TB detection products. Additionally, the device showed 89.9% sensitivity at 67.7% specificity, and 89.5% sensitivity at 70.2% specificity, meeting the World Health Organization (WHO) target product profile.
Researchers at the Heidelberg University Hospital in Germany and the Stop TB Partnership at UNOPS assessed the 12 products using data from South Africa’s national TB prevalence survey. The study involved...
Today's Sponsors
Today's Sponsor